78 related articles for article (PubMed ID: 29027701)
1. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
[TBL] [Abstract][Full Text] [Related]
2. Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.
Gozé C; Blonski M; Le Maistre G; Bauchet L; Dezamis E; Page P; Varlet P; Capelle L; Devaux B; Taillandier L; Duffau H; Pallud J
Neuro Oncol; 2014 Aug; 16(8):1100-9. PubMed ID: 24847087
[TBL] [Abstract][Full Text] [Related]
3. Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.
Euskirchen P; Radke J; Schmidt MS; Schulze Heuling E; Kadikowski E; Maricos M; Knab F; Grittner U; Zerbe N; Czabanka M; Dieterich C; Miletic H; Mørk S; Koch A; Endres M; Harms C
PLoS One; 2017; 12(9):e0185376. PubMed ID: 28945795
[TBL] [Abstract][Full Text] [Related]
4. Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.
Fortin J; Tian R; Zarrabi I; Hill G; Williams E; Sanchez-Duffhues G; Thorikay M; Ramachandran P; Siddaway R; Wong JF; Wu A; Apuzzo LN; Haight J; You-Ten A; Snow BE; Wakeham A; Goldhamer DJ; Schramek D; Bullock AN; Dijke PT; Hawkins C; Mak TW
Cancer Cell; 2020 Mar; 37(3):308-323.e12. PubMed ID: 32142668
[TBL] [Abstract][Full Text] [Related]
5. BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Morales-Gallel R; Ulloa-Navas MJ; García-Tárraga P; Prat-Acín R; Reynés G; Pérez-Borredá P; Rubio L; Capilla-González V; Ferrer-Lozano J; García-Verdugo JM
Oncotarget; 2024 Jan; 15():49-64. PubMed ID: 38275289
[TBL] [Abstract][Full Text] [Related]
6. Distinct immune escape and microenvironment between RG-like and pri-OPC-like glioma revealed by single-cell RNA-seq analysis.
Xian W; Asad M; Wu S; Bai Z; Li F; Lu J; Zu G; Brintnell E; Chen H; Mao Y; Zhou G; Liao B; Wu J; Wang E; You L
Front Med; 2024 Feb; 18(1):147-168. PubMed ID: 37955814
[TBL] [Abstract][Full Text] [Related]
7. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.
Filbin MG; Tirosh I; Hovestadt V; Shaw ML; Escalante LE; Mathewson ND; Neftel C; Frank N; Pelton K; Hebert CM; Haberler C; Yizhak K; Gojo J; Egervari K; Mount C; van Galen P; Bonal DM; Nguyen QD; Beck A; Sinai C; Czech T; Dorfer C; Goumnerova L; Lavarino C; Carcaboso AM; Mora J; Mylvaganam R; Luo CC; Peyrl A; Popović M; Azizi A; Batchelor TT; Frosch MP; Martinez-Lage M; Kieran MW; Bandopadhayay P; Beroukhim R; Fritsch G; Getz G; Rozenblatt-Rosen O; Wucherpfennig KW; Louis DN; Monje M; Slavc I; Ligon KL; Golub TR; Regev A; Bernstein BE; Suvà ML
Science; 2018 Apr; 360(6386):331-335. PubMed ID: 29674595
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor expression in human gliomas.
Torp SH; Helseth E; Dalen A; Unsgaard G
Cancer Immunol Immunother; 1991; 33(1):61-4. PubMed ID: 2021959
[TBL] [Abstract][Full Text] [Related]
9. Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
Masui K; Cloughesy TF; Mischel PS
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):271-91. PubMed ID: 22098029
[TBL] [Abstract][Full Text] [Related]
10. Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2.
Modrek AS; Golub D; Khan T; Bready D; Prado J; Bowman C; Deng J; Zhang G; Rocha PP; Raviram R; Lazaris C; Stafford JM; LeRoy G; Kader M; Dhaliwal J; Bayin NS; Frenster JD; Serrano J; Chiriboga L; Baitalmal R; Nanjangud G; Chi AS; Golfinos JG; Wang J; Karajannis MA; Bonneau RA; Reinberg D; Tsirigos A; Zagzag D; Snuderl M; Skok JA; Neubert TA; Placantonakis DG
Cell Rep; 2017 Oct; 21(5):1267-1280. PubMed ID: 29091765
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.
Hayes J; Yu Y; Jalbert LE; Mazor T; Jones LE; Wood MD; Walsh KM; Bengtsson H; Hong C; Oberndorfer S; Roetzer T; Smirnov IV; Clarke JL; Aghi MK; Chang SM; Nelson SJ; Woehrer A; Phillips JJ; Solomon DA; Costello JF
Neuro Oncol; 2018 Apr; 20(5):632-641. PubMed ID: 29077933
[TBL] [Abstract][Full Text] [Related]
12. Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways.
Fack F; Tardito S; Hochart G; Oudin A; Zheng L; Fritah S; Golebiewska A; Nazarov PV; Bernard A; Hau AC; Keunen O; Leenders W; Lund-Johansen M; Stauber J; Gottlieb E; Bjerkvig R; Niclou SP
EMBO Mol Med; 2017 Dec; 9(12):1681-1695. PubMed ID: 29054837
[TBL] [Abstract][Full Text] [Related]
13. The Role of ATRX in Glioma Biology.
Nandakumar P; Mansouri A; Das S
Front Oncol; 2017; 7():236. PubMed ID: 29034211
[TBL] [Abstract][Full Text] [Related]
14. RNA Profiling of the Human and Mouse Spinal Cord Stem Cell Niches Reveals an Embryonic-like Regionalization with MSX1
Ghazale H; Ripoll C; Leventoux N; Jacob L; Azar S; Mamaeva D; Glasson Y; Calvo CF; Thomas JL; Meneceur S; Lallemand Y; Rigau V; Perrin FE; Noristani HN; Rocamonde B; Huillard E; Bauchet L; Hugnot JP
Stem Cell Reports; 2019 May; 12(5):1159-1177. PubMed ID: 31031189
[TBL] [Abstract][Full Text] [Related]
15. A Personalized Longitudinal Strategy in Low-Grade Glioma Patients: Predicting Oncological and Neural Interindividual Variability and Its Changes over Years to Think One Step Ahead.
Duffau H
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294760
[TBL] [Abstract][Full Text] [Related]
16. RNA Profiling of Mouse Ependymal Cells after Spinal Cord Injury Identifies the Oncostatin Pathway as a Potential Key Regulator of Spinal Cord Stem Cell Fate.
Chevreau R; Ghazale H; Ripoll C; Chalfouh C; Delarue Q; Hemonnot-Girard AL; Mamaeva D; Hirbec H; Rothhut B; Wahane S; Perrin FE; Noristani HN; Guerout N; Hugnot JP
Cells; 2021 Nov; 10(12):. PubMed ID: 34943841
[TBL] [Abstract][Full Text] [Related]
17. SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme.
Guelfi S; Orsetti B; Deleuze V; Rigau V; Bauchet L; Duffau H; Rothhut B; Hugnot JP
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771555
[TBL] [Abstract][Full Text] [Related]
18. The Role of Neurodevelopmental Pathways in Brain Tumors.
Curry RN; Glasgow SM
Front Cell Dev Biol; 2021; 9():659055. PubMed ID: 34012965
[TBL] [Abstract][Full Text] [Related]
19. Identification of CRYAB
Augustus M; Pineau D; Aimond F; Azar S; Lecca D; Scamps F; Muxel S; Darlix A; Ritchie W; Gozé C; Rigau V; Duffau H; Hugnot JP
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925547
[TBL] [Abstract][Full Text] [Related]
20. CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas.
Ahn JW; Park Y; Kang SJ; Hwang SJ; Cho KG; Lim J; Kwack K
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
